Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

angiofollicular lymph node hyperplasia

(AN-jee-oh-fuh-LIH-kyoo-ler limf node HY-per-PLAY-zhuh)
A rare disorder in which benign (not cancer) growths form in lymph node tissue. There are two main ways that angiofollicular lymph node hyperplasia occurs: localized (unicentric) and multicentric. Unicentric angiofollicular lymph node hyperplasia affects only one group of lymph nodes in one part of the body, usually in the chest or abdomen. It may not cause symptoms. Multicentric angiofollicular lymph node hyperplasia affects many groups of lymph nodes and lymphoid tissue all through the body. It can weaken the immune system and cause problems such as infection, fever, weight loss, fatigue, night sweats, nerve damage, and anemia. People with angiofollicular lymph node hyperplasia have an increased risk of lymphoma. Also called Castleman disease and giant lymph node hyperplasia.
Search NCI's Dictionary of Cancer Terms